Legionella Testing Market is projected to grow from USD 296 million in 2022 to USD 439 million by 2027, at a CAGR of 8.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. The increasing need for rapid diagnostics, increasing incidence of disease, growing advancements in bacterial testing, and water testing regulations. However, a lack of reimbursement and difficulties in detection may affect market growth.
Browse in-depth TOC on “Legionella Testing Market”
146 – Tables
47 – Figures
208 – Pages
Download Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333
List of Key Players:
The major players operating in this legionella testing market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).
Legionella Testing Market Dynamics
Drivers: Rapid increase of pneumonia and Legionella-related illnesses
According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires' disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases. In addition, according to the US CDC (March 2022), the age-standardized average incidence was 0.48 cases per 100,000 population during 1992–2002, compared with 2.71/100,000 in 2018.
Opportunities: Legal requirements for water testing
The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow. In addition, the Safe Drinking Water Act (SDWA) allows individual states to set and enforce their own drinking water standards if the standards are at least as stringent as the EPA's national standards.
Restraints: lack of reimbursement policies
The major factor restraining the growth of the market is inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This decline and additional budgetary concerns among healthcare systems will be a major obstacle to implementing novel diagnostic techniques in clinical laboratories.
Challenges: Difficulties in detection
The most common cause of Legionnaire's disease is Legionella pneumophilia serogroup 1, which can be quickly and easily identified via the urine antigen test. Legionnaire's disease can also go undetected once a patient is diagnosed with pneumonia. Best practises dictate that all hospital-acquired pneumonia patients be tested for Legionella in hopes of detecting and preventing a possible outbreak.
North America is the largest regional market for legionella testing market
The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The North American market growth can be attributed to the growing incidence of legionella-related diseases and growing elderly population.
Recent Developments
· IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company’s international reference laboratory presence.
· LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
· Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173145333
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
